DNA Sequencing Technology
Sign up today and learn more about Genapsys Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Genapsys Stock
GenapSys is a sequencing technology company that aims to help support the control and limit the spread of current and future outbreaks. The company's main goal is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.
In July 2022, Genapsys filed for Chapter 11 bankruptcy.
GenapSys was founded in 2010 and is headquartered in Redwood City, California. Notable investors include Decheng Capital, Oxford Finance Corporation, and Farallon Capital Management.
Chief Executive Officer
Chief Financial Officer